BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 9499080)

  • 1. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.
    Xiao X; Li J; Samulski RJ
    J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
    Collaco RF; Cao X; Trempe JP
    Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for highly regulated rep gene expression in adeno-associated virus vector production.
    Li J; Samulski RJ; Xiao X
    J Virol; 1997 Jul; 71(7):5236-43. PubMed ID: 9188591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
    Fan PD; Dong JY
    Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
    Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
    Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes.
    Qiao C; Li J; Skold A; Zhang X; Xiao X
    J Virol; 2002 Feb; 76(4):1904-13. PubMed ID: 11799185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
    Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W
    Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.
    Cao L; Liu Y; During MJ; Xiao W
    J Virol; 2000 Dec; 74(24):11456-63. PubMed ID: 11090141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.
    Allen JM; Halbert CL; Miller AD
    Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
    Whiteway A; Deru W; Prentice HG; Anderson R
    J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system.
    Feudner E; de Alwis M; Thrasher AJ; Ali RR; Fauser S
    J Virol Methods; 2001 Aug; 96(2):97-105. PubMed ID: 11445141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.
    Grimm D; Kay MA; Kleinschmidt JA
    Mol Ther; 2003 Jun; 7(6):839-50. PubMed ID: 12788658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-Associated Virus Vector Mobilization, Risk Versus Reality.
    Song L; Samulski RJ; Hirsch ML
    Hum Gene Ther; 2020 Oct; 31(19-20):1054-1067. PubMed ID: 32829671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
    Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
    Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.
    Smith RH; Afione SA; Kotin RM
    Biotechniques; 2002 Jul; 33(1):204-6, 208, 210-1. PubMed ID: 12139247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
    Shiau AL; Liu PS; Wu CL
    J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.